|
|
||||||||
Ann Thorac Surg 2002;73:1041-1048
© 2002 The Society of Thoracic Surgeons
a Division of Thoracic and Cardiovascular Surgery, University of Virginia Health Sciences Center, Charlottesville, Virginia, USA
* Address reprint requests to Dr Kron, Department of Thoracic and Cardiovascular Surgery, University of Virginia Health Sciences Center, Lee St, Rm 2753, Charlottesville, VA 22908, USA
e-mail: ikron{at}virginia.edu
Presented at the Forty-eighth Annual Meeting of the Southern Thoracic Surgical Association, San Antonio, TX, Nov 810, 2001.
Background. Bronchiolitis obliterans syndrome (BOS) is the most common cause of long-term morbidity and mortality after lung transplantation. Our hypothesis was that early ischemia-reperfusion injury after lung transplantation increases the risk of BOS.
Methods. Data on 134 patients who had lung transplantation between January 1, 1990 and January 1, 2000, was used for univariate and multivariate logistic regression analysis.
Results. After lung transplantation, 115 patients (115 of 134, 86%) survived more than 3 months. In that group, 41 patients developed BOS, of which 23 had progressive disease. Univariate analysis revealed that ischemia-reperfusion injury (p = 0.017) and two or more acute rejection episodes (p = 0.032) were predictors of BOS onset, whereas ischemia-reperfusion injury (p = 0.011) and cytomegalovirus infection (p = 0.009) predicted progressive BOS. Multivariate logistic regression analysis showed that ischemia-reperfusion injury was an independent predictor for both BOS development and BOS progression. Two or more acute rejection episodes were also an independent predictor of BOS development, whereas cytomegalovirus infection was an independent predictor of progressive BOS.
Conclusions. Ischemia-reperfusion injury increases the risk of BOS after lung transplantation.
This article has been cited by other articles:
![]() |
P. Ferraro, J. Martin, J. Dery, J. Prenovault, L. Samson, M. Coutu, L.-Q. Chen, C. Poirier, N. Noiseux, A. Duranceau, et al. Late retrograde perfusion of donor lungs does not decrease the severity of primary graft dysfunction. Ann. Thorac. Surg., October 1, 2008; 86(4): 1123 - 1129. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Kohmoto, A. Nakao, R. Sugimoto, Y. Wang, J. Zhan, H. Ueda, and K. R. McCurry Carbon monoxide-saturated preservation solution protects lung grafts from ischemia-reperfusion injury. J. Thorac. Cardiovasc. Surg., October 1, 2008; 136(4): 1067 - 1075. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Burton, M. Iversen, J. Carlsen, C. Andersen, and J. Mortensen The effect of baseline lung function on the determination of time to bronchiolitis obliterans syndrome Eur. Respir. Rev., June 1, 2008; 17(108): 90 - 92. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. S. Wolf, H. E. Merry, A. S. Farivar, A. S. McCourtie, and M. S. Mulligan Stress-activated protein kinase inhibition to ameliorate lung ischemia reperfusion injury J. Thorac. Cardiovasc. Surg., March 1, 2008; 135(3): 656 - 665. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. McCourtie, H. E. Merry, A. S. Farivar, C. H. Goss, and M. S. Mulligan Alveolar Macrophage Secretory Products Augment the Response of Rat Pulmonary Artery Endothelial Cells to Hypoxia and Reoxygenation Ann. Thorac. Surg., March 1, 2008; 85(3): 1056 - 1060. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Gazoni, C. G. Tribble, M. Q. Zhao, E. B. Unger, R. A. Farrar, P. I. Ellman, L. G. Fernandez, V. E. Laubach, and I. L. Kron Pulmonary Macrophage Inhibition and Inhaled Nitric Oxide Attenuate Lung Ischemia-Reperfusion Injury Ann. Thorac. Surg., July 1, 2007; 84(1): 247 - 253. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-F. Cordier Challenges in pulmonary fibrosis {middle dot} 2 : Bronchiolocentric fibrosis Thorax, July 1, 2007; 62(7): 638 - 649. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Nowak, S. Weih, R. Metzger, R. F. Albrecht II, S. Post, P. Hohenberger, M.-M. Gebhard, and S. M. Danilov Immunotargeting of catalase to lung endothelium via anti-angiotensin-converting enzyme antibodies attenuates ischemia-reperfusion injury of the lung in vivo Am J Physiol Lung Cell Mol Physiol, July 1, 2007; 293(1): L162 - L169. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Daud, R. D. Yusen, B. F. Meyers, M. M. Chakinala, M. J. Walter, A. A. Aloush, G. A. Patterson, E. P. Trulock, and R. R. Hachem Impact of Immediate Primary Lung Allograft Dysfunction on Bronchiolitis Obliterans Syndrome Am. J. Respir. Crit. Care Med., March 1, 2007; 175(5): 507 - 513. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Burton, M. Iversen, N. Milman, M. Zemtsovski, J. Carlsen, D. Steinbruchel, J. Mortensen, and C. B. Andersen Outcome of lung transplanted patients with primary graft dysfunction Eur. J. Cardiothorac. Surg., January 1, 2007; 31(1): 75 - 82. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Shimamoto, T. H. Pohlman, S. Shomura, T. Tarukawa, M. Takao, and H. Shimpo Toll-Like Receptor 4 Mediates Lung Ischemia-Reperfusion Injury Ann. Thorac. Surg., December 1, 2006; 82(6): 2017 - 2023. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Mathur, M. Baz, E. D. Staples, M. Bonnell, J. M. Speckman, P. J. Hess Jr, C. T. Klodell, D. G. Knauf, L. L. Moldawer, and T. M. Beaver Cytokine profile after lung transplantation: correlation with allograft injury. Ann. Thorac. Surg., May 1, 2006; 81(5): 1844 - 1850. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Dodd-o, M. L. Hristopoulos, L. E. Welsh-Servinsky, C. G. Tankersley, and D. B. Pearse Strain-specific differences in sensitivity to ischemia-reperfusion lung injury in mice J Appl Physiol, May 1, 2006; 100(5): 1590 - 1595. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Farivar, M. F. Delgado, A. S. McCourtie, A. D. Barnes, E. D. Verrier, and M. S. Mulligan Crosstalk Between Thrombosis and Inflammation in Lung Reperfusion Injury. Ann. Thorac. Surg., March 1, 2006; 81(3): 1061 - 1067. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. T. Schnickel, D. J. Ross, R. Beygui, A. Shefizadeh, H. Laks, R. Saggar, J. P. Lynch III, and A. Ardehali Modified reperfusion in clinical lung transplantation: The results of 100 consecutive cases J. Thorac. Cardiovasc. Surg., January 1, 2006; 131(1): 218 - 223. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Belperio, M. P. Keane, M. D. Burdick, B. N. Gomperts, Y. Y. Xue, K. Hong, J. Mestas, D. Zisman, A. Ardehali, R. Saggar, et al. CXCR2/CXCR2 Ligand Biology during Lung Transplant Ischemia-Reperfusion Injury J. Immunol., November 15, 2005; 175(10): 6931 - 6939. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. I. Ellman, J. S. Alvis, C. Tache-Leon, R. Singh, T. B. Reece, J. A. Kern, C. G. Tribble, and I. L. Kron Hyperoxic ventilation exacerbates lung reperfusion injury J. Thorac. Cardiovasc. Surg., November 1, 2005; 130(5): 1440 - 1440. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Christie, R. M. Kotloff, V. N. Ahya, G. Tino, A. Pochettino, C. Gaughan, E. DeMissie, and S. E. Kimmel The Effect of Primary Graft Dysfunction on Survival after Lung Transplantation Am. J. Respir. Crit. Care Med., June 1, 2005; 171(11): 1312 - 1316. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Farivar, B. C. Mackinnon-Patterson, A. D. Barnes, A. S. McCourtie, and M. S. Mulligan Cyclosporine Modulates the Response to Hypoxia-Reoxygenation in Pulmonary Artery Endothelial Cells Ann. Thorac. Surg., March 1, 2005; 79(3): 1010 - 1016. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Keshavjee, R.D. Davis, M.R. Zamora, M. de Perrot, and G.A. Patterson A randomized, placebo-controlled trial of complement inhibition in ischemia-reperfusion injury after lung transplantation in human beings J. Thorac. Cardiovasc. Surg., February 1, 2005; 129(2): 423 - 428. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Goto, A. Ishizaka, F. Kobayashi, M. Kohno, M. Sawafuji, S. Tasaka, E. Ikeda, Y. Okada, I. Maruyama, and K. Kobayashi Importance of Tumor Necrosis Factor-{alpha} Cleavage Process in Post-Transplantation Lung Injury in Rats Am. J. Respir. Crit. Care Med., December 1, 2004; 170(11): 1239 - 1246. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. de Perrot, K. Young, Y. Imai, M. Liu, T. K. Waddell, S. Fischer, L. Zhang, and S. Keshavjee Recipient T Cells Mediate Reperfusion Injury after Lung Transplantation in the Rat J. Immunol., November 15, 2003; 171(10): 4995 - 5002. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E. Reed General thoracic surgery and the Southern Thoracic Surgical Association: the second 25 years Ann. Thorac. Surg., November 1, 2003; 76(90050): S14 - 16. [Full Text] [PDF] |
||||
![]() |
M. O. Meade, J. T. Granton, A. Matte-Martyn, K. McRae, B. Weaver, P. Cripps, and S. H. Keshavjee A Randomized Trial of Inhaled Nitric Oxide to Prevent Ischemia-Reperfusion Injury after Lung Transplantation Am. J. Respir. Crit. Care Med., June 1, 2003; 167(11): 1483 - 1489. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. de Perrot, M. Liu, T. K. Waddell, and S. Keshavjee Ischemia-Reperfusion-induced Lung Injury Am. J. Respir. Crit. Care Med., February 15, 2003; 167(4): 490 - 511. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |